01 1Laurus Labs
01 1EFAVIRENZ USP (PROCESS-2)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-02
Pay. Date : 2012-11-13
DMF Number : 26242
Submission : 2012-07-17
Status : Active
Type : II
20
Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EFAVIRENZ USP (PROCESS-2), with a corresponding US DMF Number 26242.
Remarkably, this DMF maintains an Active status since its submission on July 17, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2013, and payment made on November 13, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
